stockrow
Friday 6 November 2026
Export MDXHF’s income statement to Excel — free account
MedX Health Corp.
MDXHF Healthcare Diagnostics & Research
MedX Health Corp.’s revenue for fiscal 2025 (year ended December 2025) was $338,700.00, down 5.23% from fiscal 2024.
- Revenue
- +33.6%
- EPS
- −6.06%
- Free cash flow
- +41.6%
- Total debt
- −8.75%
Quarter to June 2026, against a year earlier
0.03
0.00
0.00%
Follow MDXHF
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 6 | 4 | 5 | 4 | — | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
8.75 | 0.00 | 0.02 | 0.01 | 0.26 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(157.11) | (104.48) | (3.57) | (4.07) | (4.49) | (11.30) | (11.51) | (5.20) | — | (1.88) |
Altman Z″-Score (non-manufacturers) |
(415.54) | (274.96) | (8.78) | (9.46) | (6.88) | (25.44) | (22.86) | (6.04) | — | 0.24 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(3.70) | 0.00 | (0.15) | (0.03) | (1.68) | (0.40) | (0.49) | (0.47) | (0.47) | (0.47) |
Beneish M-Score |
— | (14.89) | (2.86) | 0.63 | (2.76) | (4.84) | — | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.15 | 0.03 | 0.20 | 1.40 | 0.23 | 0.17 | 0.17 | 0.17 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 10.32 | 0.36 | 0.27 | 0.27 | 0.27 |
EV/Sales |
12.29 | 5.93 | 0.26 | 0.63 | (0.95) | 0.24 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 4.33 | 0.77 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.56) | (1.16) | (0.86) | (0.69) | 0.63 | (0.13) | 0.00 | 0.00 | 0.00 | 0.00 |
EV/FCF |
(0.79) | (0.47) | (0.62) | (0.60) | 0.63 | (0.13) | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
0.01 | 0.05 | 1.71 | 1.36 | 3.84 | 1.51 | 2.76 | 3.95 | 2.80 | 3.93 |
Current Ratio |
0.04 | 0.10 | 1.95 | 1.59 | 4.05 | 1.77 | 2.96 | 4.17 | 3.00 | 4.09 |
Net Debt/EBITDA |
(0.40) | (1.29) | (0.85) | (0.66) | 1.84 | 0.04 | 0.33 | 0.87 | 1.48 | 2.80 |
Debt/Assets |
241.50% | 346.44% | 30.81% | 32.42% | 19.60% | 47.44% | 27.08% | 0.80% | 0.00% | 0.79% |
Debt/Equity |
(0.17) | (0.36) | 5.52 | 4.15 | 0.31 | 2.58 | 0.56 | 0.01 | 0.02 | 0.01 |
Asset Turnover |
0.59 | 0.01 | 0.57 | 0.38 | 0.42 | 0.48 | 0.22 | 0.46 | 1.28 | 0.45 |
Operating CF/Net income |
0.59 | 0.69 | 0.50 | 0.77 | 0.78 | 0.71 | 0.52 | 0.89 | 0.85 | 1.26 |
Capex/Depreciation |
(0.04) | (34.74) | (0.40) | (0.57) | (0.30) | (0.16) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
(2.44) | (1.71) | (1.49) | (6.26) | (12.42) | (17.58) | (141.09) | (627.83) | — | (4,373.67) |
| 68.26% | (540.15%) | (521.70%) | (156.70%) | (109.96%) | (204.65%) | (118.02%) | (72.01%) | (27.25%) | (26.03%) | |
| (784.34%) | (4.11%) | (34.72%) | (45.36%) | (54.25%) | (73.96%) | (80.10%) | (52.22%) | (38.84%) | (19.85%) | |
ROIC |
0.00% | 0.00% | (69.39%) | (77.00%) | (538.20%) | (338.36%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
66.31% | 49.04% | (182.67%) | (300.40%) | (55.94%) | (259.55%) | (187.95%) | (84.37%) | (45.47%) | (30.52%) |
Average Days of Receivables |
97.96 | 219.06 | 57.66 | 92.17 | 75.20 | 74.56 | 207.35 | 245.91 | 168.69 | 237.51 |
Research and Development Expense of Revenue |
105.64% | 107.47% | 9.08% | 20.39% | 30.01% | 24.61% | 21.78% | 10.93% | 7.20% | 4.43% |
Selling, General and Administrative Expense of Revenue |
789.78% | 402.63% | 86.03% | 130.76% | 138.19% | 165.89% | 261.93% | 151.56% | 92.67% | 99.92% |
Intangible Assets out of Total Assets |
155.90 | 118.58 | 0.62 | 0.69 | 0.05 | 0.16 | 0.18 | 0.24 | 0.00 | 0.21 |
Share Based Compensation of Revenue |
183.20% | 28.26% | 0.95% | 2.34% | 5.49% | 7.02% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(2.42) | 0.00 | (76.20) | (256.07) | 4.11 | (0.36) | 2.24 | 3.17 | 3.17 | 3.17 |
Graham Number |
0.09 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(152.00%) | 0.00% | (2,850.00%) | (9,500.00%) | (899.17%) | (1,143.78%) | (1,143.78%) | (1,143.78%) | (1,143.78%) | (1,143.78%) |
Free Cash Flow Yield |
(178.45%) | 0.00% | (2,726.26%) | (12,294.31%) | (585.61%) | (677.37%) | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.00 | 0.00 | 2.70 | 2.36 | 0.18 | 2.22 | 2.12 | 5.67 | 0.87 | 0.62 |
Operating CF per Share |
(0.01) | (0.01) | (0.83) | (2.17) | (0.19) | (2.43) | (4.06) | (5.77) | (0.22) | (0.34) |
Capex per Share |
0.00 | 0.00 | (0.11) | (0.18) | (0.01) | (0.06) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.01) | (0.01) | (0.93) | (2.35) | (0.19) | (2.50) | (4.06) | (5.77) | (0.22) | (0.34) |
Cash per Share |
0.00 | 0.00 | 0.86 | 0.99 | 0.48 | 1.92 | 3.96 | 5.23 | 0.34 | 0.67 |
Shareholders Equity per Share |
(0.02) | (0.02) | 0.28 | 0.59 | 0.39 | 0.70 | 3.54 | 10.40 | 0.88 | 1.14 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.02) | (0.02) | 0.28 | 0.59 | 0.39 | 0.70 | 3.54 | 10.40 | 0.88 | 1.14 |
Free Cash Flow |
(2.67) | (3.02) | (24.24) | (36.91) | (23.44) | (20.78) | (25.41) | (33.26) | (11.20) | (15.78) |
Working Capital |
(7.00) | (5.46) | 18.64 | 10.87 | 50.17 | 10.07 | 23.01 | 41.82 | 26.29 | 38.82 |
Capital Expenditures |
0.00 | (1.19) | (2.75) | (2.79) | (0.90) | (0.54) | (0.08) | (1.55) | (5.19) | (4.65) |
Net Current Asset Value |
(7.18) | (6.25) | (83.76) | (80.67) | 38.43 | (2.92) | 11.24 | 39.66 | 24.42 | 36.43 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 46.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 3.32 | 0.04 | 0.08 | 0.04 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.18 | 1.19 | 1.38 | 1.29 | 1.82 | 3.42 | 1.39 | 1.42 | 0.78 | 0.73 |
Cash ROIC |
46.51% | 78.05% | (34.95%) | (58.18%) | (19.52%) | (56.29%) | (42.85%) | (36.70%) | (18.23%) | (18.79%) |
Accounts Receivable Turnover |
2.22 | 0.06 | 6.87 | 5.32 | 5.32 | 3.27 | 0.90 | 1.55 | 2.24 | 1.48 |
Accounts Payable Turnover |
0.22 | 0.04 | 2.77 | 2.02 | 1.83 | 1.91 | 3.35 | 3.13 | 2.18 | 1.84 |
Inventory Turnover |
1.84 | 0.14 | 10.29 | 8.42 | 5.51 | 5.69 | 9.98 | 8.38 | 7.79 | 6.58 |
Average Days of Payables |
1,700.43 | 2,945.56 | 122.45 | 208.30 | 233.07 | 186.42 | 119.25 | 100.23 | 168.29 | 196.82 |
Days of Inventory on Hand |
130.17 | 465.22 | 38.62 | 47.62 | 59.74 | 81.44 | 28.67 | 45.21 | 53.07 | 48.15 |
Average Receivables |
0.15 | 5.65 | 10.22 | 6.97 | 4.18 | 5.65 | 14.76 | 20.99 | 19.28 | 19.28 |
Average Payables |
1.75 | 5.28 | 9.49 | 8.82 | 6.39 | 5.45 | 5.09 | 5.36 | 6.07 | 6.07 |
Average Inventory |
0.20 | 1.53 | 2.55 | 2.12 | 2.12 | 1.83 | 1.71 | 2.00 | 1.70 | 1.70 |
Average Assets |
0.57 | 64.89 | 124.13 | 97.10 | 53.46 | 38.75 | 60.45 | 71.42 | 33.79 | 63.15 |
Average Common Equity |
(6.60) | 0.49 | 8.26 | 28.11 | 26.37 | 14.01 | 41.03 | 51.80 | 48.16 | 48.16 |
Columns are period end dates · fundamentals updated 26 Oct 2026